Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

34.68
-1.5900-4.38%
Post-market: 34.60-0.0809-0.23%18:02 EST
Volume:978.38K
Turnover:34.16M
Market Cap:2.76B
PE:42.29
High:36.61
Open:35.49
Low:34.56
Close:36.27
52wk High:50.71
52wk Low:22.61
Shares:79.46M
Float Shares:78.23M
Volume Ratio:0.84
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8200
EPS(LYR):0.8200
ROE:5.34%
ROA:2.91%
PB:2.10
PE(LYR):42.29

Loading ...

Veracyte Inc. Director Jens Holstein Reports Disposal of Common Shares

Reuters
·
Nov 22, 2025

Veracyte (VCYT): Evaluating Valuation After Recent Share Price Gain and Growth Headlines

Simply Wall St.
·
Nov 19, 2025

Cathie Wood Bets Big on This Peter Thiel-Backed Coinbase Rival as Bitcoin Crashes Below $91,000

Benzinga
·
Nov 18, 2025

Veracyte Inc. VP and Chief Accounting Officer Jonathan Wygant Reports Disposal of Common Shares

Reuters
·
Nov 13, 2025

Veracyte (VCYT): Exploring Valuation After Recent Share Price Rally

Simply Wall St.
·
Nov 12, 2025

Veracyte Is Maintained at Underweight by Morgan Stanley

Dow Jones
·
Nov 12, 2025

Veracyte Shares Surge 20% as Analyst Upgrades Spark Fresh Valuation Debate

Simply Wall St.
·
Nov 09, 2025

Veracyte Director Karin Eastham Reports Sale of Common Shares

Reuters
·
Nov 08, 2025

Veracyte CFO Rebecca Chambers Reports Sale of Common Shares

Reuters
·
Nov 08, 2025

Veracyte (VCYT) Gets a Buy from Craig-Hallum

TIPRANKS
·
Nov 06, 2025

Veracyte Inc. to Participate in Major Investor Conferences

Reuters
·
Nov 06, 2025

Veracyte Inc. Reports Robust Q3 Earnings Performance

TIPRANKS
·
Nov 06, 2025

Veracyte Up Over 26%, On Track for Largest Percent Increase Since October 2018 -- Data Talk

Dow Jones
·
Nov 06, 2025

Veracyte rises 21.4%

TIPRANKS
·
Nov 06, 2025

Stock Track | Veracyte Soars 16.18% on Stellar Q3 Results and Raised 2025 Outlook

Stock Track
·
Nov 05, 2025

Veracyte price target raised to $43 from $40 at Canaccord

TIPRANKS
·
Nov 05, 2025

UBS Adjusts Price Target on Veracyte to $48 From $42, Maintains Buy Rating

MT Newswires Live
·
Nov 05, 2025

Veracyte Inc : Leerink Partners Raises Target Price to $50 From $45

THOMSON REUTERS
·
Nov 05, 2025

Veracyte Is Maintained at Buy by Needham

Dow Jones
·
Nov 05, 2025

Veracyte’s Strong Financial Performance and Promising Pipeline Justify Buy Rating

TIPRANKS
·
Nov 05, 2025